On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

WNT10A

Wnt family member 10A

Chromosome 2q35 Autosomal recessive HGNC:13829 Tier C
WNT10A 2q35 p arm q arm 2

WNT10A is located on the long (q) arm of chromosome 2, at band 2q35. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 2 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

WNT10A belongs to the WNT gene family, a group of developmental regulators that orchestrate cell-to-cell communication during embryonic growth. The protein product functions as a signalling molecule, activating pathways that determine how cells specialise and organise into tissues before birth. This gene plays a particularly important role in forming ectodermal structures - tissues arising from the outermost embryonic cell layer that eventually become skin, hair follicles, teeth, nails and sweat glands.

Variants that disrupt WNT10A function interfere with normal ectodermal development, leading to a spectrum of conditions collectively termed ectodermal dysplasias. The most common presentation is hypohidrotic ectodermal dysplasia, characterised by reduced sweating capacity, sparse hair, and dental abnormalities. Because WNT10A-related conditions follow autosomal recessive inheritance, two altered copies of the gene are typically required for disease manifestation.

What the gene does

The WNT10A protein acts as an extracellular signalling ligand, binding to receptors on nearby cells to trigger intracellular cascades that regulate gene expression. When WNT10A engages its receptors, it activates pathways that control whether embryonic cells divide, differentiate into specialised types, or undergo programmed death. This signalling mechanism is essential for patterning tissues during development, ensuring that structures form in the correct locations and proportions.

Research indicates that WNT10A signalling is especially critical during the formation of skin appendages - the specialised structures that include hair follicles, tooth buds, nail beds and sweat gland precursors. The protein helps establish the initial organisation of these structures during embryonic development and influences their subsequent maturation. Evidence suggests that WNT10A signalling remains active during the transition from primary to permanent dentition, coordinating the replacement of baby teeth with adult teeth. Disruption of this signalling pathway at any developmental stage can result in malformed or absent ectodermal structures, with the specific consequences depending on when and where WNT10A function is compromised.

Video: Genetics 101

Chromosome location

The WNT10A gene resides on chromosome 2 at position 2q35, within the long arm of the chromosome. This chromosomal region contains several other genes involved in developmental processes. The gene spans multiple exons encoding the full-length transcript, which is translated into a 417-amino-acid protein. The genomic organisation allows for regulated expression during specific developmental windows when ectodermal tissue formation occurs.

Protein structure

The WNT10A protein comprises 417 amino acids and contains structural features characteristic of the WNT protein family, including cysteine residues that form disulphide bonds essential for proper protein folding and secretion. A disordered region extends from amino acids 300 to 331, a segment that lacks fixed three-dimensional structure and may provide flexibility for protein-protein interactions or post-translational modifications. This disordered segment could play a role in modulating the protein's signalling activity or stability, though its precise functional contribution remains an area of ongoing investigation.

Key variants

Pathogenic variants in WNT10A most commonly result in loss of protein function, either through premature truncation of the protein, disruption of critical cysteine residues required for folding, or interference with the protein's ability to engage its receptors. The variant spectrum includes nonsense mutations that introduce early stop codons, frameshift deletions or insertions, and missense changes affecting conserved amino acids. Because the gene follows autosomal recessive inheritance, individuals typically require variants in both gene copies to develop clinical features, though carrier status with a single variant does not usually produce symptoms.

No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.

Associated conditions

Variants in WNT10A cause multiple forms of ectodermal dysplasia, a group of conditions affecting structures derived from the embryonic ectoderm. Hypohidrotic ectodermal dysplasia represents the most frequently observed presentation, marked by reduced sweating ability, sparse scalp and body hair, and dental abnormalities including missing or malformed teeth. Additional WNT10A-related conditions include odonto-onycho-dermal dysplasia, which features dental anomalies alongside fingernail and toenail defects and thickened skin on palms and soles, and Schopf-Schulz-Passarge syndrome. The clinical severity and specific features vary depending on the nature and location of the genetic variants, with some individuals experiencing milder presentations affecting primarily dental development whilst others have more widespread ectodermal involvement.

No condition pages are linked to this gene yet. This does not mean it has no associated conditions.

Inheritance pattern

Conditions caused by pathogenic WNT10A variants typically follow autosomal recessive inheritance.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Carrier frequency by population How common is heterozygous WNT10A carrier status across ancestry groups?

UK clinical status

WNT10A appears on the NHS Genomic Medicine Service PanelApp resource under panels for ectodermal dysplasia conditions, reflecting its established role in these disorders. The gene holds green (diagnostic-grade) classification on both the Ectodermal dysplasia panel (R163) and the Ectodermal dysplasia without a known gene mutation panel, indicating strong evidence supporting its clinical validity for diagnostic testing in individuals presenting with relevant clinical features. This classification status means WNT10A analysis may be included in genomic testing for patients evaluated through NHS clinical genetics services when ectodermal dysplasia is suspected.

Green-listed
High evidence · clinically actionable in NHS testing
Included in NHS GMS signed-off panels

Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory

Frequently asked questions

How is WNT10A inherited?

WNT10A-related conditions follow autosomal recessive inheritance, meaning an individual typically needs to inherit a pathogenic variant from both parents to develop features of ectodermal dysplasia. Carriers with one altered copy generally do not show symptoms.

What types of symptoms result from WNT10A variants?

Individuals with WNT10A-related conditions may experience reduced ability to sweat, sparse or absent hair, missing or malformed teeth, and abnormalities of the nails. The specific combination and severity of features varies between affected individuals.

Can WNT10A variants affect only teeth?

Some individuals with WNT10A variants present primarily with dental abnormalities such as missing permanent teeth or unusually shaped teeth, whilst other ectodermal features remain mild or absent. The phenotypic spectrum is broad and can include isolated dental findings.

Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 17 April 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .